Moreover, IL-17 suppresses fibrosis via the STAT-3 and WAP domain protein pathways in models of T1D and T2D, and tubulointerstitial fibrosis can be rescued by suppressing intrarenal IL-17A1 CD41 T cells (41, 44). Here, ITGA2B is linked to type 1 diabetes mellitus.